Company Filing History:
Years Active: 2020-2021
Title: The Innovative Contributions of Przemyslaw Skoczen
Introduction
Przemyslaw Skoczen, a prominent inventor based in Straszyn, Poland, has made significant strides in the pharmaceutical field through his innovative work. With a focus on creating effective oral pharmaceutical preparations, Skoczen has been granted two patents that showcase his dedication to advancing medical treatments.
Latest Patents
Skoczen's latest inventions include a patented process for the preparation of an enteric coated granulate comprising dimethyl fumarate. This innovative process results in an oral pharmaceutical preparation that is essential in the treatment of multiple sclerosis. The granulate is formulated with pharmaceutically acceptable excipients, ensuring its efficacy in delivering the intended drug.
Additionally, he has developed crystalline forms of apremilast, specifically Forms N, M, O, and P. This invention is particularly relevant in the pharmaceutical industry, offering distinct crystalline forms that can be utilized in various dosage forms or compositions. The novelty of these crystalline forms holds promise for enhancing treatment options for various diseases and disorders.
Career Highlights
Przemyslaw Skoczen works at Zakłady Farmaceutyczne Polpharma S.A., where he continues to contribute to pharmaceutical innovations. His role allows him to collaborate with other talented professionals in the field, driving forward advancements in drug formulation and delivery.
Collaborations
Throughout his career, Skoczen has collaborated closely with colleagues such as Aleksandra Drozd and Marek Cichocki. These partnerships have fostered a productive environment for brainstorming and developing cutting-edge solutions in pharmaceutical preparations, underscoring the importance of teamwork in the innovation process.
Conclusion
Przemyslaw Skoczen stands out as a vital contributor to the world of pharmaceuticals. His inventions not only reflect his innovative spirit but also hold the potential to significantly impact treatments for conditions such as multiple sclerosis. As he continues his work at Zakłady Farmaceutyczne Polpharma S.A., Skoczen's contributions are a testament to the ongoing evolution of medical science through innovation.